Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prediction of everolimus-induced interstitial lung disease in breast cancer patients
2013-002258-60Phase 4Terminated
- Sponsor
- Radboud University Medical Center
- Start
- Aug 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of everolimus in breast cancer, sponsored by Radboud University Medical Center. Started Aug 2013; status: terminated.
02
Drugs
everolimus
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2013-002258-60.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-002258-60.